Lipocalin 2 Is Required for Pulmonary Host Defense against <i>Klebsiella</i> Infection

Yvonne R. Chan(University of Pittsburgh), Jessica S. Liu(Pulmonary and Allergy Associates), Derek Pociask(Children's Hospital of Pittsburgh), Mingquan Zheng(Children's Hospital of Pittsburgh), Timothy A. Mietzner(University of Pittsburgh), Thorsten Berger(Ontario Institute for Cancer Research), Tak W. Mak(Ontario Institute for Cancer Research), Matthew C. Clifton(Fred Hutch Cancer Center), Roland K. Strong(Fred Hutch Cancer Center), Prabir Ray(Pulmonary and Allergy Associates), Jay K. Kolls(Children's Hospital of Pittsburgh)
The Journal of Immunology
April 1, 2009
Cited by 219Open Access
Full Text

Abstract

Antimicrobial proteins comprise a significant component of the acute innate immune response to infection. They are induced by pattern recognition receptors as well as by cytokines of the innate and adaptive immune pathways and play important roles in infection control and immunomodulatory homeostasis. Lipocalin 2 (siderocalin, NGAL, 24p3), a siderophore-binding antimicrobial protein, is critical for control of systemic infection with Escherichia coli; however, its role in mucosal immunity in the respiratory tract is unknown. In this study, we found that lipocalin 2 is rapidly and robustly induced by Klebsiella pneumoniae infection and is TLR4 dependent. IL-1beta and IL-17 also individually induce lipocalin 2. Mucosal administration of IL-1beta alone could reconstitute the lipocalin 2 deficiency in TLR4 knockout animals and rescue them from infection. Lipocalin 2-deficient animals have impaired lung bacterial clearance in this model and mucosal reconstitution of lipocalin 2 protein in these animals resulted in rescue of this phenotype. We conclude that lipocalin 2 is a crucial component of mucosal immune defense against pulmonary infection with K. pneumoniae.


Related Papers

No related papers found

Powered by citation graph analysis